Healthcare provider profile · identity verified

David J Scarpelli, MD

Family Practice · YORK, PA · NPI 1366462053

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	575	144
Lisinopril	Lisinopril	393	102
Escitalopram Oxalate	Escitalopram Oxalate	360	69
Omeprazole	Omeprazole	330	73
Amlodipine Besylate	Amlodipine Besylate	321	84
Levothyroxine Sodium	Levothyroxine Sodium	298	67
Metoprolol Succinate	Metoprolol Succinate	285	75
Simvastatin	Simvastatin	231	57
Eliquis	Apixaban	220	47
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	216	61
Atenolol	Atenolol	206	52
Tamsulosin Hcl	Tamsulosin Hcl	166	46
Rosuvastatin Calcium	Rosuvastatin Calcium	160	47
Losartan Potassium	Losartan Potassium	158	42
Furosemide	Furosemide	154	39
Alprazolam	Alprazolam	152	37
Pantoprazole Sodium	Pantoprazole Sodium	120	29
Gabapentin	Gabapentin	111	29
Hydrochlorothiazide	Hydrochlorothiazide	106	26
Allopurinol	Allopurinol	102	29
Finasteride	Finasteride	97	28
Metformin Hcl	Metformin Hcl	93	29
Potassium Chloride	Potassium Chloride	93	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	86	21
Metoprolol Tartrate	Metoprolol Tartrate	85	21
Pravastatin Sodium	Pravastatin Sodium	79	20
Albuterol Sulfate Hfa	Albuterol Sulfate	74	31
Meloxicam	Meloxicam	74	18
Carvedilol	Carvedilol	64	18
Celecoxib	Celecoxib	64	15
Tramadol Hcl	Tramadol Hcl	60	18
Xarelto	Rivaroxaban	58	15
Citalopram Hbr	Citalopram Hydrobromide	57	14
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	56	15
Spironolactone	Spironolactone	55	15
Ropinirole Hcl	Ropinirole Hcl	53	suppressed
Sertraline Hcl	Sertraline Hcl	51	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	50	suppressed
Jardiance	Empagliflozin	49	16
Clopidogrel	Clopidogrel Bisulfate	45	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	43	41
Amitriptyline Hcl	Amitriptyline Hcl	41	12
Esomeprazole Magnesium	Esomeprazole Magnesium	40	11
Fluticasone Propionate	Fluticasone Propionate	40	12
Alendronate Sodium	Alendronate Sodium	39	13
Zolpidem Tartrate	Zolpidem Tartrate	39	13
Prednisone	Prednisone	38	26
Triamcinolone Acetonide	Triamcinolone Acetonide	38	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Trazodone Hcl	Trazodone Hcl	36	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	35	suppressed
Synthroid	Levothyroxine Sodium	34	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	33	suppressed
Famotidine	Famotidine	33	suppressed
Hydralazine Hcl	Hydralazine Hcl	32	suppressed
Glimepiride	Glimepiride	31	suppressed
Benazepril Hcl	Benazepril Hcl	29	suppressed
Glipizide Er	Glipizide	29	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	29	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	29	11
Valsartan	Valsartan	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	suppressed
Diazepam	Diazepam	25	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Ipratropium Bromide	Ipratropium Bromide	25	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	21
Bupropion Xl	Bupropion Hcl	24	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	24	suppressed
Lorazepam	Lorazepam	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Trulicity	Dulaglutide	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Midodrine Hcl	Midodrine Hcl	20	suppressed
Montelukast Sodium	Montelukast Sodium	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Sotalol	Sotalol Hcl	19	suppressed
Azithromycin	Azithromycin	18	14
Ondansetron Hcl	Ondansetron Hcl	18	suppressed
Cephalexin	Cephalexin	17	14
Klor-Con M20	Potassium Chloride	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Amoxicillin	Amoxicillin	16	11
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Aripiprazole	Aripiprazole	15	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	15	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	14	suppressed
Clonazepam	Clonazepam	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Fluconazole	Fluconazole	13	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	13	suppressed
Mesalamine Dr	Mesalamine	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	13	suppressed
Baclofen	Baclofen	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Estradiol	Estradiol	12	suppressed
Flecainide Acetate	Flecainide Acetate	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Metformin Hcl Er	Metformin Hcl	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Duloxetine Hcl	Duloxetine Hcl	11	suppressed
Entresto	Sacubitril/Valsartan	11	suppressed
Januvia	Sitagliptin Phosphate	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Tradjenta	Linagliptin	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error